Pain: the use of paracetamol in multimorbid patients
Keywords:
Pain treatment, paracetamol, elderlyAbstract
Introduction: More than one third of Italians have at least 2 chronic comorbidities, and this percentage is more than 50% after the age of 75 years. The presence of comorbidities has as a consequence politreatments, with a high probability of drug interactions and adverse events.
Methods: Medical literature about physiopathology of pain and its treatments was reviewed and combined with expert opinion of the authors.
Results: Pain is “An unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage”. Chronic pain is one of the main factors that impact on quality of life and is the leading reason why patients seek medical care.
Pain can represent a defense against potential or real damage to the body, but chronic pain becomes a disease itself, with a profound negative impact on quality of life. Paracetamol is a drug with analgesic and antipyretic action widely used both alone and in combination with other medications. It is an effective and safe drug, and can be used in infants and elderly, in patients in whom NSAIDs are contraindicated, in pregnant or breastfeeding women. A large number of studies have recognized the efficacy and safety of paracetamol in treating pain, and the drug is included in the WHO's List of Essential Medicines. EULAR, AAOS and NICE guidelines recommend paracetamol as the first-choice analgesic in several conditions like osteoarthritis or post-surgical pain.
Conclusions: Paracetamol, due to its efficacy, safety of use, poor interaction with other drugs, appears to be the first-choice treatment of painful syndromes in the elderly patient.
References
AIFA. Pazienti con multimorbilità, la gestione della politerapia e i rischi delle interazioni farmacologiche. 8/4/2015. Available from https://www.aifa.gov.it/-/pazienti-con-multimorbilita-la-gestione-della-politerapia-e-i-rischi-delle-interazioni-farmacologiche
American Academy of Orthopaedic Surgeons/Major Extremity Trauma and Rehabilitation Consortium. Clinical Practice Guideline for Pharmacologic, Physical, and Cognitive Pain Alleviation for Musculoskeletal Extremity/Pelvis Surgery. Published July 19, 2021. Available from https://www.aaos.org/painalleviationcpg
Anderson BJ. Paracetamol (Acetaminophen): mechanisms of action. Paediatr Anaesth 2008;18:915-21
Beltramo M, Stella N, Calignano A, et al. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 1997;277:1094-7
Bonezzi C, Lora Aprile P, Fornasari D. Terapia farmacologica combinata del dolore: l’asso nella manica del medico di medicina generale. Rivista Società Italiana di Medicina Generale. 2017; 6(24): 25-32
Derry S, Moore RA. Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults. Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD008040.
Gaul C, Eschalier A. Dose Can Help to Achieve Effective Pain Relief for Acute Mild to Moderate Pain with Over-the-Counter Paracetamol. The Open Pain Journal, 2018; 11:12-20
Geenen R, Overman CL, Christensen R, Åsenlöf P, Capela S, Huisinga KL et al. EULAR recommendations for the health professional’s approach to pain management in inflammatory arthritis and osteoarthritis. Ann Rheum Dis 2018;77:797–807
Gossec L, Baraliakos X, Kerschbaumer A, de Wit M, McInnes I, Dougados M et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis 2020;79:700–712.
Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacol. 2013; 21:201–232
Hoshijima H, Hunt M, Nagasaka H, Yaksh T. Effects of Acetaminophen in Preclinical Models of Nociceptive Processing. J Pain Res. 2021; 14:3521-3552
Institute of Medicine (US) Committee on Pain, Disability, and Chronic Illness Behavior. Anatomy and Physiology of Pain. In: Osterweis M, Kleinman A, Mechanic D (Eds), Pain and Disability: Clinical, Behavioral, and Public Policy Perspectives; National Academies Press, Washington (DC) 1987:123-145
ISTAT Report Anno 2015. Anziani: le condizioni di salute in Italia e nell’Unione Europea. 26/9/2017. Available from https://www.istat.it/it/archivio/203820
ISTAT Report Anno 2019. Le condizioni di salute della popolazione anziana in Italia. 14/7/2021. Available from https://www.istat.it/it/files/2021/07/Report-anziani-2019.pdf
Jahr JS, Breitmeyer JB, Pan C, Royal MA, Ang RY. Safety and Efficacy of Intravenous Acetaminophen in the Elderly After Major Orthopedic Surgery. American Journal of Therapeutics. 2012 March; 19(2): 66-75
Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Annals of the Rheumatic Diseases 2003;62(12):1145-55.
Kaas Oldenburg LI, Dalhoff KP, Sandoval LØ, and Vermehren C. The Risk of Drug-Drug Interactions with Paracetamol in a Population of Hospitalized Geriatric Patients. Journal of Pharmaceutics. 2020, Article ID 1354209, 9 pages
Kenshalo DR, Giesler GJ, Leonard RB, and Willis WD. Responses of neurons in primate ventral posterior lateral nucleus to noxious stimula. Journal of Neurophysiology. 1980;43:1594-1614.
Lipton RB, Baggish JS, Stewart W, Codispoti JR, Fu M. Efficacy and Safety of Acetaminophen in the Treatment of Migraine. Results of a Randomized, Double-blind, Placebo-Controlled, Population-Based Study. Journal of Pain Research 2021:14 3521–3552
Magni A, Fornasari D, Lapi F, Lora Aprile P. Paracetamolo e osteoartrosi: “facciamo il punto”. Rivista Società Italiana di Medicina Generale. 2017; 5(24):48-51
Mahadevan SBK, McKiernan PJ, Davies P, D A Kelly Paracetamol induced hepatotoxicity. Arch Dis Child 2006;91:598–603
Mian P, Allegaert K, Spriet I, Tibboel D, Petrovic M. Paracetamol in Older People: Towards Evidence‐Based Dosing? Drugs & Aging (2018) 35:603–624
NICE 2022: Guidelines on fractures (non-complex): assessment and management. Published: 17 February 2016. Available from https://www.nice.org.uk/guidance/ng38/chapter/Recommendations#initial-pain-management-and-immobilisation
NICE 2022: Guidelines on Hip fracture: management. Updated 10 May 2017. Available from https://www.nice.org.uk/guidance/cg124/chapter/Recommendations#analgesia
NICE 2022: Osteoarthritis care and management. Updated 11 Dec 2020. https://www.nice.org.uk/guidance/cg177/chapter/Recommendations#pharmacological-management
NICE 2022: Perioperative care in adults. Published 19 August 2020. https://www.nice.org.uk/guidance/ng180/chapter/Recommendations#managing-pain
Ohashi N and Kohno T. Analgesic Effect of Acetaminophen: A Review of Known and Novel Mechanisms of Action. Front Pharmacol. 2020; 11:580289.
Paracetamol SmPC
Peck J, Urits I, Zeien J, Hoebee S, Mousa M, Alattar H et al. A Comprehensive Review of Over-the-counter Treatment for Chronic Migraine Headaches. Curr Pain Headache Rep. 2020 Mar 21; 24(5)19
Raja SN, Carr DB, Cohen M, Finnerup NB, Flor H, Gibson S et al. The Revised IASP definition of pain: concepts, challenges, and compromises. Pain. 2020 September 01; 161(9): 1976–1982.
Saxena A, Balaramnavar VM, Hohlfeld T, Saxena AK. Drug/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets. Eur J Pharmacol. 2013;721:215-24.
Schneider J, Algharably EAE, Budnick A, Wenzel A, Dräger D, Kreutz R. High Prevalence of Multimorbidity and Polypharmacy in Elderly Patients With Chronic Pain Receiving Home Care are Associated With Multiple Medication-Related Problems. Front Pharmacol. 2021 Jun 8;12:686990.
Schofield P, Dunham M, Martin D, Bellamy G, Francis SA, Sookhoo D et al. Evidence-based clinical practice guidelines on the management of pain in older people – a summary report. British Journal of Pain. 2022; 16(1) 6–13
Scienze motorie: Il dolore. 18/5/2016. Available from https://www.scienzemotorie.com/dolore-definizione-classificazione-e-aspetti-psicologici
Sinatra RS, Jahr JS, Reynolds LW, Viscusi ER, Groudine SB, Payen-Champenois C. Efficacy and Safety of Single and Repeated Administration of 1 Gram Intravenous Acetaminophen Injection (Paracetamol) for Pain Management after Major Orthopedic Surgery. Anesthesiology 2005; 102:822–31
Toes MJ, Jones AL, Prescott L. Drug interactions with paracetamol Am J Ther. 2005 Jan-Feb;12(1):56-66
Troncoso-Mariño A, Roso-Llorach A, López-Jiménez T, Villen N, Amado-Guirado E, Fernández-Bertolin S et al. Medication-Related Problems in Older People with Multimorbidity in Catalonia: A Real-World Data Study with 5 Years' Follow-Up. J Clin Med. 2021 Feb 11;10(4):709.
Watson JC. Panoramica sul dolore. Updated March 2022. MDS manual. Available from https://www.msdmanuals.com/it-it/professionale/malattie-neurologiche/dolore/panoramica-sul-dolore
WHO model list of essential medicines, 20th list (March 2017, amended August 2017)
Willis WD. The pain system. The neural basis of nociceptive transmission in the mammalian nervous system. Pain Headache. 1985;8:1-346.
Published
Issue
Section
License
Copyright (c) 2022 next next
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Ma.CRO Lifescience Srl has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
